SecBot SecBot
6-K ·Filed Mar 26, 2026

NBTX

Nanobiotix S.A.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001171843-26-001941
Notable filing: 6-K
Actionable Insight • Neutral

Traders should monitor the company's earnings release on March 31 and the subsequent call on April 1 for material financial and operational updates that could impact stock price.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
NBTX ▲ +14.79% at T+60d
NEUTRAL call +14.79% · α vs SPY -1.28% · entry $29.95 → $34.38
Entry = T+0 close
Mar 26, 2026
via day close
T+1d
+2.10%
call +2.10% · α +2.46%
$30.58
settled 7mo ago
T+5d
+9.38%
call +9.38% · α +5.52%
$32.76
settled 7mo ago
T+20d
+10.55%
call +10.55% · α -2.19%
$33.11
settled 6mo ago
T+60d
+14.79%
call +14.79% · α -1.28%
$34.38
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Nanobiotix S.A. announced it will release its fourth quarter and full year 2025 financial results on March 31, 2026, followed by a conference call on April 1, 2026. The filing contains no financial data or operational updates, only logistical details for the upcoming earnings release and call.

Key Facts

  • Nanobiotix will report Q4 and full year 2025 financial results on March 31, 2026, after U.S. market close.
  • Conference call and webcast scheduled for April 1, 2026, at 8:00 AM EDT / 2:00 PM CEST.
  • No financial results, guidance, or material operational updates were disclosed in this filing.
  • The filing is a standard press release and Form 6-K submission to announce the timing of future disclosures.

Financial Impact

No financial impact from this filing; actual results will be disclosed on March 31, 2026.

Risk Factors

  • Earnings results may deviate from market expectations, leading to volatility on March 31 or April 1.
  • Lack of pre-announcement suggests no major positive or negative surprises were signaled in advance.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-001941
Document: f6k_032626.htm0001171843-26-001941
Document: 0001171843-26-001941-index-headers.html0001171843-26-001941
Document: 0001171843-26-001941-index.html0001171843-26-001941
Document: 0001171843-26-001941.txt0001171843-26-001941
25 reports for NBTX
Performance horizon
70% Hit rate @ T+20 7 of 10 directional calls Went positive at some point 7 of 10 best @ T+20▲ +55.06%Apr 20, 2026
Filters
Rows
Reports for NBTX — sortable, filterable
TypeNow
Oct 26, 2026
today
6-K
NEUTRAL ★ 4/10
—awaiting T+20——
Oct 20, 2026
6d ago
6-K
NEUTRAL ★ 1/10
$25.83awaiting T+20—$29.36 (+13.67%)
Oct 1, 2026
25d ago
6-K
NEUTRAL ★ 2/10
$25.75awaiting T+20—$29.36 (+14.02%)
Oct 1, 2026
25d ago
Press Release
NEUTRAL ★ 2/10
$25.75awaiting T+20—$29.36 (+14.02%)
Sep 24, 2026
4w ago
6-K
BEARISH ★ 6/10
$33.31 $29.36▲ +11.86%▲ +10.38%$29.36 (+11.86%)
Sep 24, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$33.31 $29.36▼ −11.86%▼ −10.38%$29.36 (−11.86%)
Sep 24, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$33.31 $29.36▼ −11.86%▼ −10.38%$29.36 (−11.86%)
Sep 22, 2026
4w ago
Press Release
NEUTRAL ★ 1/10
$35.24 $25.83▼ −26.70%▼ −27.39%$29.36 (−16.69%)
Sep 14, 2026
6w ago
6-K
BULLISH ★ 7/10
$35.73 $23.40▼ −34.51%▼ −36.77%$29.36 (−17.83%)
Jul 31, 2026
12w ago
6-K
NEUTRAL ★ 1/10
$38.89 $40.64▲ +4.50%▲ +3.26%$29.36 (−24.51%)
Showing 10 of 25

US Market Status

Market Closed — Opens Wed (12h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 26, 2026